STAT3 and osteoporosis: In summary, we revealed that BCI inhibited RANKL-mediated osteoclastogenesis by restraining STAT3 activity and NF-κB–NFATc1 signaling in vitro and ameliorating OVX-induced osteoporosis in vivo.